title: Palivizumab Prophylaxis for Healthy Preterm Infants: More Data Supporting American Academy of Pediatrics Guidelines.
authors.affiliation: Department of Pediatrics, University of Utah, Salt Lake City, Utah; and carrie.byington@hsc.utah.edu.
authors.forename: Carrie L
authors.initials: CL
authors.lastname: Byington
authors.affiliation: Department of Pediatrics, Baylor College of Medicine, Houston, Texas.
authors.forename: Flor M
authors.initials: FM
authors.lastname: Munoz
mesh_terms: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000998:Antiviral Agents; D002648:Child; D006760:Hospitalization; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007234:Infant, Premature; D000069455:Palivizumab; D010372:Pediatrics; D018357:Respiratory Syncytial Virus Infections; D014481:United States
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000998:Antiviral Agents; D000069455:Palivizumab